A Combination of Cardamonin and Doxorubicin Selectively Affect Cell Viability of Melanoma Cells: An In Vitro Study

Treatment of the most aggressive and deadliest form of skin cancer, the malignant melanoma, still has room for improvement. Its invasive nature and ability to rapidly metastasize and to develop resistance to standard treatment often result in a poor prognosis. While the highly effective standard che...

Full description

Bibliographic Details
Main Authors: Lara Ebbert, Claudia von Montfort, Chantal-Kristin Wenzel, Andreas S. Reichert, Wilhelm Stahl, Peter Brenneisen
Format: Article
Language:English
Published: MDPI AG 2024-07-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/13/7/864